Core One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer's and Parkinson's Disease Seite 1
29.07.2023 - VANCOUVER, BC / ACCESSWIRE / July 28, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6) (WKN:A3CSSU) (the 'Company' or 'Core One'), is excited to share positive results from its first round of Stage 1 animal model studies ('Round 1'), ... Seite 1